Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris
|更新时间:2024-01-04
|
Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris
Chinese Journal of Experimental Traditional Medical FormulaeVol. 17, Issue 19, Pages: 258-260(2011)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2011
稿件说明:
移动端阅览
LIU Dong-min. Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(19): 258-260.
DOI:
LIU Dong-min. Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(19): 258-260.DOI:
Clinical Observation of Shuxuening Injection and Trimetazidine on Coronary Heart Disease and Angina Pectoris
Objective: To observe the therapeutic effect of the Shuxuening injection and Trimetazidine on coronary heart disease(CHD)and angina pectoris. Method: One hundred and twenty patients were randomly divided into treatment group and control group. The control group were given routine western medicine
and the treatment group received Shuxuening injection and trimetazidine additionally. 4 weeks was a course of treatment. Result: The total effective rate was 85.00% in control group and 98.33% in treatment group on the clinical symptoms(P<0.05). The total effective rate was 60.00% in control group and 85.00% in treatment group on the electrocardiogram(P<0.05).The total cholesterol (TC)
low density lipoprotein (LDL-C) and triglyceride (TG) of the two groups was significantly lowered
and high density lipoprotein (HDL-C) was highered
and improving in the treatment group was more significant than in the control group(P<0.05). Conclusion: Shuxuening injection and Trimetazidine has significant therapeutic effect in treating CHD and angina pectoris.
Establishment and Evaluation of Rat Model of Myocardial Ischemia-reperfusion Injury with Phlegm and Blood Stasis Blocking Collaterals Syndrome Based on Metabolomics
Establishment and Evaluation of Rat Model of Acute Myocardial Infarction in Coronary Heart Disease with Qi and Yin Deficiency Syndrome Based on Sleep Deprivation Combined with Coronary Artery Ligation
Mechanism of Xuefu Zhuyutang in Intervening in Ferroptosis in Rats with Coronary Heart Disease with Blood Stasis Syndrome Based on ACSL4 Signalling Pathway
Construction of an Intelligent Diagnosis and Treatment Ontology for Traditional Chinese Medicine Based on Clinical Practice Guidelines:A Case Study of Coronary Heart Disease
Effect of Yiqi Huoxue Prescription on cAMP/Epac1/Rap1 Signaling Pathway in Coronary Heart Disease Rats with Qi Deficiency and Blood Stasis Syndrome
Related Author
HU Longxiao
GAO Jiabei
MA Weihao
LU Jieming
GAO Yunxiao
YUAN Yue
ZHANG Qiuyan
CHEN Xiaoxiao
Related Institution
Natural History Museum of China
Beijing Key Laboratory of Chinese Materia Pharmacology,National Clinical Research Center of Traditional Chinese Medicine for Cardiovascular Diseases,Institute of Basic Medical Sciences, Xiyuan Hospital,China Academy of Chinese Medical Sciences
School of Clinical Medicine,Beijing University of Chinese Medicine
Institute of Basic Medical Sciences,Xiyuan Hospital,China Academy of Chinese Medical Sciences